Danaher Corporation (DHR)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for DHR is $235.50, 2.8% above the last close of $229.04 on Oct 16, 2026; targets range from $194.65 to $266.09. Rating consensus: Buy.
Snapshot
- P/E40.7x
- P/E vs sector+44.5%
- P/E vs own+6.0%
- Target upside+2.8%
- ConsensusBuy
- Market cap$161B
- FCF yield+3.4%
- Insiders-$12.74M
- Earnings in5d
- News
Why it moved
Danaher Corporation (DHR) fell 1.1% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.
News spike: 5 stories, 3.8× the 30-day average.
- Danaher Corporation $DHR Stock: Chiron Capital Management LLC Decreases Position
- Danaher Corporation $DHR Stake Increased by Cohen Klingenstein LLC
- Danaher Corporation $DHR Shares Acquired by Aspiriant LLC
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $229.04 · +9.4% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendbullish
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▲ 200▲
- Above MAs4 of 4 above
- MA20×50—
- RSI63
- Support-2.6%
- Resistance+0.7%
- Off 52w high-4.8%
- Off ATH-20.2%
- 52w range$229.04
- Bollingerupper half
- MACD0.71
- ATR+2.6%
- Volume0.8x
Analyst price targets
16 firms with a target in the last 12 months · last close $229.04 · as of Oct 16, 2026
Strong buy 5 · Buy 17 · Hold 4 · Sell 0 · Strong sell 0
Revenue and free cash flow
Q2 FY2026: Revenue +5.5% year over year, free cash flow 20.2% of revenue, operating margin 18.0%.
| Q2 FY2026 | Jun 26, 2026 | $6.26B | 1.23 | $1.26B | 57.6% | 18.0% | 13.9% |
| Q1 FY2026 | Mar 27, 2026 | $5.95B | 1.45 | $1.08B | 60.3% | 22.6% | 17.3% |
| Q4 FY2025 | Dec 31, 2025 | $6.84B | 1.68 | $1.75B | 58.0% | 22.0% | 17.5% |
| Q3 FY2025 | Sep 26, 2025 | $6.05B | 1.27 | $1.37B | 58.2% | 19.1% | 15.0% |
| Q2 FY2025 | Jun 27, 2025 | $5.94B | 0.77 | $1.09B | 66.6% | 20.1% | 9.3% |
| Q1 FY2025 | Mar 28, 2025 | $5.74B | 1.32 | $1.05B | 61.2% | 22.2% | 16.6% |
| Q4 FY2024 | Dec 31, 2024 | $6.54B | 1.49 | $1.5B | 59.5% | 26.7% | 16.6% |
| Q3 FY2024 | Sep 27, 2024 | $5.8B | 1.12 | $1.22B | 58.7% | 16.5% | 14.1% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $690.00 | -0.9% | -0.9% | -3.3% | 37.1 | $255B | |
| 2 | | $229.04 | -1.1% | -4.8% | +2.8% | 40.7 | $161B | |
| 3 |  | $172.97 | -1.5% | -1.5% | +0.5% | 34.0 | $48.77B | |
| 4 |  | $560.36 | +2.4% | -26.9% | +34.9% | 39.7 | $44.15B | |
| 5 |  | $266.90 | -1.5% | -3.0% | +3.6% | 33.1 | $43.93B | |
| 6 |  | $436.95 | -1.6% | -1.6% | +4.4% | 109.0 | $42.9B | |
| 7 |  | $262.54 | -2.0% | -10.6% | -16.6% | 49.0 | $39.64B | |
| 8 |  | $1,622.29 | -1.0% | -1.0% | -7.3% | 36.5 | $32.51B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.